BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19493561)

  • 1. Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients.
    Tardy B; Venet C; Zeni F; Coudrot M; Guyomarc'h S; Mismetti P
    Thromb Res; 2009 Dec; 124(6):672-7. PubMed ID: 19493561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
    Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator for hemodynamically stable patients experiencing an acute pulmonary embolism: a meta-analysis.
    Liu Y; Lu Y; Song J; Li D; Liu H; Yang J; Zhao H
    Thromb Res; 2014 Jul; 134(1):50-6. PubMed ID: 24824292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute pulmonary embolism].
    Meissner E; Niedermeyer J; Fabel H
    Z Kardiol; 1993; 82 Suppl 2():3-12. PubMed ID: 8328207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?
    Worster A; Smith C; Silver S; Brown MD
    Ann Emerg Med; 2007 Jul; 50(1):78-84. PubMed ID: 17449142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism.
    Zamanian RT; Gould MK
    Curr Opin Pulm Med; 2008 Sep; 14(5):422-6. PubMed ID: 18664972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis.
    Becattini C; Vedovati MC; Agnelli G
    Circulation; 2007 Jul; 116(4):427-33. PubMed ID: 17606843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful thrombolysis of submassive pulmonary embolism after bariatric surgery: expanding the indications and addressing the controversies.
    Pulipati RC; Lazzaro RS; Macura J; Savel RH
    Obes Surg; 2003 Oct; 13(5):792-6. PubMed ID: 14627480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism.
    Perlroth DJ; Sanders GD; Gould MK
    Arch Intern Med; 2007 Jan; 167(1):74-80. PubMed ID: 17210881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The thrombolytic treatment of acute and subacute recurrent pulmonary embolism with recombinant tissue plasminogen activator].
    Tiede N; Kasper W; Geibel A; Bassenge D; Langenstein B; Meinertz T; Just H
    Dtsch Med Wochenschr; 1990 Nov; 115(45):1699-704. PubMed ID: 2121453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of thrombolysis for the treatment of acute pulmonary embolism].
    Marbet GA
    Schweiz Med Wochenschr; 1989 Oct; 119(43):1498-505. PubMed ID: 2514456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.
    Zhang Z; Zhai ZG; Liang LR; Liu FF; Yang YH; Wang C
    Thromb Res; 2014 Mar; 133(3):357-63. PubMed ID: 24412030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of long-term clinical outcome of patients with acute massive pulmonary embolism after thrombolytic therapy.
    Liu P; Meneveau N; Schiele F; Bassan JP
    Chin Med J (Engl); 2003 Apr; 116(4):503-9. PubMed ID: 12875711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism].
    Nielsen HK; Lassen JF; Ravn HB; Husted SE
    Ugeskr Laeger; 1995 May; 157(20):2835-40. PubMed ID: 7785097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy for the treatment of acute pulmonary embolism.
    Anderson DR; Levine MN
    CMAJ; 1992 Apr; 146(8):1317-24. PubMed ID: 1555162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [rt-PA in extracardiac thromboembolic vascular occlusions].
    Cortellaro M; Cofrancesco E; Polli EE
    Ann Ital Med Int; 1990; 5(1):61-9. PubMed ID: 2119673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of the thrombolytic therapy for acute pulmonary thromboembolism: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research.
    Nakamura M; Nakanishi N; Yamada N; Sakuma M; Miyahara Y; Okada O; Tanabe N; Kuriyama T; Kunieda T; Shirato K; Sugimoto T; Nakano T
    Int J Cardiol; 2005 Mar; 99(1):83-9. PubMed ID: 15721504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biohumoral markers and right ventricular dysfunction in acute pulmonary embolism: the answer to thrombolytic therapy].
    Enea I; Ceparano G; Mazzarella G; Di Sarno R; Cangiano G; Busino CA
    Ital Heart J Suppl; 2004 Jan; 5(1):29-35. PubMed ID: 15253142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: a meta-analysis.
    Riera-Mestre A; Becattini C; Giustozzi M; Agnelli G
    Thromb Res; 2014 Dec; 134(6):1265-71. PubMed ID: 25457585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic treatment of acute pulmonary embolism.
    Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
    Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.